Skip Navigation

JNCI Monographs 2006 2006(36):15-19; doi:10.1093/jncimonographs/lgj004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Rosenberg, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenberg, M. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org.

Chapter 3: Competing Risks to Breast Cancer Mortality

Marjorie A. Rosenberg

Correspondence to: Marjorie A. Rosenberg, PhD, School of Business and Department of Biostatistics and Medical Informatics, University of Wisconsin–Madison, 975 University Ave., Madison, WI 53706 (e-mail: mrosenberg{at}bus.wisc.edu).

Background: Simulation models analyzing the impact of treatment interventions and screening on the level of breast cancer mortality require an input of mortality from causes other than breast cancer, or competing risks. Methods: This chapter presents an actuarial method of creating cohort life tables using published data that removes breast cancer as a cause of death. Results: Mortality from causes other than breast cancer as a percentage of all-cause mortality is smallest for women in their forties and fifties, as small as 85% of the all-cause rate, although the level and percentage of the impact varies by birth cohort. Conclusion: This method produces life tables by birth cohort and by age that are easily included as a common input by the various CISNET modeling groups to predict mortality from other causes. Attention to removing breast cancer mortality from all-cause mortality is worthwhile, because breast cancer mortality can be as high as 15% at some ages.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Natl Cancer Inst MonogrHome page
E. J. Feuer
Chapter 1: Modeling the Impact of Adjuvant Therapy and Screening Mammography on U.S. Breast Cancer Mortality Between 1975 and 2000: Introduction to the Problem
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 2 - 6.
[Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
D. A. Berry, L. Inoue, Y. Shen, J. Venier, D. Cohen, M. Bondy, R. Theriault, and M. F. Munsell
Chapter 6: Modeling the Impact of Treatment and Screening on U.S. Breast Cancer Mortality: A Bayesian Approach
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 30 - 36.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
D. G. Fryback, N. K. Stout, M. A. Rosenberg, A. Trentham-Dietz, V. Kuruchittham, and P. L. Remington
Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 37 - 47.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
S. Y. G. L. Tan, G. J. van Oortmarssen, H. J. de Koning, R. Boer, and J. D. F. Habbema
Chapter 9: The MISCAN-Fadia Continuous Tumor Growth Model for Breast Cancer
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 56 - 65.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
S. Lee and M. Zelen
Chapter 11: A Stochastic Model for Predicting the Mortality of Breast Cancer
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 79 - 86.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
S. K. Plevritis, B. M. Sigal, P. Salzman, J. Rosenberg, and P. Glynn
Chapter 12: A Stochastic Simulation Model of U.S. Breast Cancer Mortality Trends From 1975 to 2000
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 86 - 95.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
L. D. Clarke, S. K. Plevritis, R. Boer, K. A. Cronin, and E. J. Feuer
Chapter 13: A Comparative Review of CISNET Breast Models Used To Analyze U.S. Breast Cancer Incidence and Mortality Trends
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 96 - 105.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
J. D. F. Habbema, S. Y. G. L. Tan, and K. A. Cronin
Chapter 14: Impact of Mammography on U.S. Breast Cancer Mortality, 1975-2000: Are Intermediate Outcome Measures Informative?
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 105 - 111.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
J. D. F. Habbema, C. B. Schechter, K. A. Cronin, L. D. Clarke, and E. J. Feuer
Chapter 16: Modeling Cancer Natural History, Epidemiology, and Control: Reflections on the CISNET Breast Group Experience
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 122 - 126.
[Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
K. A. Cronin, A. B. Mariotto, L. D. Clarke, and E. J. Feuer
Chapter 5: Additional Common Inputs for Analyzing Impact of Adjuvant Therapy and Mammography on U.S. Mortality
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 26 - 29.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.